News
LZAGF
805.50
NaN%
--
Weekly Report: what happened at LZAGF last week (1102-1106)?
Weekly Report · 2d ago
Merck exits U.S. CDMO operations in sale to Lonza
Seeking Alpha · 11/03 07:45
Lonza to Buy U.S. Sites From Germany's Merck
Dow Jones · 11/03 06:28
*Lonza: Deal Is for Enterprise Valuation in Low- to Mid-Triple-Digit Millions Swiss Francs
Dow Jones · 11/03 06:08
*Lonza Backs 2026 View
Dow Jones · 11/03 06:08
*Lonza to Buy Five CDMO Manufacturing Sites from Germany's Merck KGaA
Dow Jones · 11/03 06:07
*Lonza: Transaction Will Strengthen Lonza's End-To-End Offering in the U.S.
Dow Jones · 11/03 06:07
Weekly Report: what happened at LZAGF last week (1026-1030)?
Weekly Report · 11/02 10:21
Weekly Report: what happened at LZAGF last week (1019-1023)?
Weekly Report · 10/26 10:21
Weekly Report: what happened at LZAGF last week (1012-1016)?
Weekly Report · 10/19 10:21
Weekly Report: what happened at LZAGF last week (1005-1009)?
Weekly Report · 10/12 10:26
Weekly Report: what happened at LZAGF last week (0928-1002)?
Weekly Report · 10/05 10:26
Weekly Report: what happened at LZAGF last week (0921-0925)?
Weekly Report · 09/28 10:21
Weekly Report: what happened at LZAGF last week (0914-0918)?
Weekly Report · 09/21 10:21
Weekly Report: what happened at LZAGF last week (0907-0911)?
Weekly Report · 09/14 10:26
Weekly Report: what happened at LZAGF last week (0831-0904)?
Weekly Report · 09/07 10:19
Weekly Report: what happened at LZAGF last week (0824-0828)?
Weekly Report · 08/31 10:27
Weekly Report: what happened at LZAGF last week (0817-0821)?
Weekly Report · 08/24 10:28
Artisan Global Opportunities Fund Q2 2026 Portfolio Review
Seeking Alpha · 08/19 05:10
Weekly Report: what happened at LZAGF last week (0810-0814)?
Weekly Report · 08/17 10:29
More
Webull provides a variety of real-time LZAGF stock news. You can receive the latest news about Lonza Group Ag through multiple platforms. This information may help you make smarter investment decisions.
About LZAGF
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.